Association between ERCC2 rs13181 polymorphism and ovarian cancer risk: an updated meta-analysis with 4024 subjects

被引:0
作者
JieNa Li
Lei Pan
Xia Qin
HongYan Chu
HuiYing Mu
GuoXing Wan
机构
[1] Heze Municipal Hospital,Department of Obstetrics and Gynecology
[2] Dongming People’s Hospital,Department of Obstetrics and Gynecology
[3] Hubei University of Medicine,Department of Oncology, Renmin Hospital
来源
Archives of Gynecology and Obstetrics | 2017年 / 296卷
关键词
ERCC2; Polymorphism; Ovarian cancer; Meta-analysis; Risk;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:551 / 558
页数:7
相关论文
共 153 条
[1]  
Jia HM(2017)Prognostic value of MMP-2 for patients with ovarian epithelial carcinoma: a systematic review and meta-analysis Arch Gynecol Obstet 295 689-696
[2]  
Zhang QY(2002)Polymorphisms in DNA repair and environmental interactions Mutat Res 509 201-210
[3]  
Liu FX(2010)Interactions between exposure to environmental polycyclic aromatic hydrocarbons and DNA repair gene polymorphisms on bulky DNA adducts in human sperm PLoS One 5 e13145-943
[4]  
Zhou DS(2015)Nucleotide excision repair (NER) alterations as evolving biomarkers and therapeutic targets in epithelial cancers Oncoscience 2 942-216
[5]  
de Boer JG(2014)The effect of XPD/ERCC2 Lys751Gln polymorphism on acute leukemia risk: a systematic review and meta-analysis Gene 538 209-188
[6]  
Ji G(1998)Mutations in the XPD helicase gene result in XP and TTD phenotypes, preventing interaction between XPD and the p44 subunit of TFIIH Nat Genet 20 184-11259
[7]  
Gu A(2014)Association between the XPD/ERCC2 Lys751Gln polymorphism and risk of cancer: evidence from 224 case–control studies Tumour Biol 35 11243-330
[8]  
Zhou Y(2007)Importance of xeroderma pigmentosum group D polymorphisms in susceptibility to ovarian cancer Cancer Lett 246 324-560
[9]  
Shi X(2003)Measuring inconsistency in meta-analyses BMJ 327 557-188
[10]  
Xia Y(1986)Meta-analysis in clinical trials Control Clin Trials 7 177-748